04/18
Headlines

ALNY

FB Nasdaq FB Facebook

Hot BiotecH Stocks: Alnylam Pharmaceuticals (NASDAQ:ALNY), Sangamo Biosciences (NASDAQ:SGMO), Dyax Corp. (NASDAQ:DYAX), Synthetic Biologics Inc (NYSEMKT:SYN)

Kevin Long02 mins

It was the biggest loser on the Bloomberg Massachusetts Index: Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), down more than 12 percent. The Cambridge company is developing a new class of medicines based on RNA interference, or RNAi. Alnylam believes that RNAi therapeutics are a promising approach to silence disease-causing genes, according to its website. Alnylam Pharmaceuticals, Inc….

Read More

Biotech Volatile Stocks: NewLink Genetics Corp (NASDAQ:NLNK), Alnylam Pharmaceuticals (NASDAQ:ALNY), Kindred Biosciences (NASDAQ:KIN), Agenus (NASDAQ:AGEN)

John Bellich02 mins

NewLink Genetics Corp (NASDAQ:NLNK)’s algenpantucel-L is expected to garner the highest sales and will be launched in both resectable and unresectable locally-advanced settings. Other drugs with significant forecast sales by 2017 include Threshold Pharmaceuticals/Merck’s TH-302 and Merrimack Pharmaceuticals’ MM-398,” director says. NewLink Genetics Corp (NASDAQ:NLNK) stock performance was -9.03% in last session and finished the…

Read More

Mix Sector Stocks News: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Wipro Ltd. (NYSE:WIT), Franco-Nevada Corporation (NYSE:FNV), ICF International Inc. (NASDAQ:ICFI), Avnet, Inc. (NYSE:AVT)

John Meady02 mins

On Jan 20, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), announced that it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $450 million. All of the shares in the offering are to be sold by Alnylam. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) belongs to Healthcare sector. Its weekly performance is…

Read More

Volatile Stocks: Prosensa Holding (NASDAQ:RNA), 22nd Century Group Inc (NYSEMKT:XXII), Alnylam Pharmaceuticals (NASDAQ:ALNY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Colin Pettis03 mins

Prosensa Holding NV (NASDAQ:RNA) was upgraded by stock analysts at KBC Securities from a “hold” rating to an “accumulate” rating in a report issued on Wednesday. The firm currently has a $11.00 price objective on the stock, up from their previous price objective of $7.00. KBC Securities’ target price would indicate a potential upside of…

Read More

Mid Cap Bullish Stocks : Puma Biotechnology Inc (NYSE:PBYI), J2 Global Inc (NASDAQ:JCOM), Alnylam Pharmaceuticals (NASDAQ:ALNY), athenahealth (NASDAQ:ATHN)

Chris Lewis02 mins

Puma Biotechnology Inc (NYSE:PBYI), a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an overview of the Company at 11:20 a.m. PDT on Wednesday, May 14, at the Bank of America Merrill Lynch 2014 Health Care Conference. The conference will be held at…

Read More